New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the cardiac arrhythmia suppression trial and its pilot study
Open Access
- 30 April 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 23 (5) , 1130-1140
- https://doi.org/10.1016/0735-1097(94)90601-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The prevalence of proarrhythmic events during moricizine therapy and their relationship to ventricular functionAmerican Heart Journal, 1992
- Arrhythmogenic effects of antiarrhythmic drugs: A study of 506 patients treated for ventricular tachycardia or fibrillationJournal of the American College of Cardiology, 1989
- Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine®)The American Journal of Cardiology, 1989
- Clinical Characteristics of Patients with Ventricular Fibrillation during Antiarrhythmic Drug TherapyNew England Journal of Medicine, 1988
- Proarrhythmia, arrhythmogenesis or aggravation of arrhythmia—A status report, 1987The American Journal of Cardiology, 1987
- Aggravation of arrhythmia by antiarrhythmic drugs—Incidence and predictorsThe American Journal of Cardiology, 1987
- Risk factors for the development of proarrhythmic eventsThe American Journal of Cardiology, 1987
- Proarrhythmic effects of antiarrhythmic drugsThe American Journal of Cardiology, 1987
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- "Les Torsades de Pointes": An Unusual Ventricular ArrhythmiaAnnals of Internal Medicine, 1980